Alcohol use disorder (AUD) is a complex brain disorder with an array of persistent behavioral and neurochemical manifestations. Both genetic and environmental factors are known to contribute to the development of AUD, and recent studies on alcohol exposure and subsequent changes in gene expression suggest the importance of epigenetic mechanisms. In particular, histone modifications and DNA methylation have emerged as important regulators of gene expression and associated phenotypes of AUD. Given the therapeutic potential of epigenetic targets, this review aims to summarize the role of epigenetic regulation in our current understanding of AUD by evaluating known epigenetic signatures of brain regions critical to addictive behaviors in both animal and human studies throughout various stages of AUD. More specifically, the effects of acute and chronic alcohol exposure, tolerance, and postexposure withdrawal on epigenetically induced changes to gene expression and synaptic plasticity within key brain regions and the associated behavioral phenotypes have been discussed. Understanding the contribution of epigenetic regulation to crucial signaling pathways may prove vital for future development of novel biomarkers and treatment agents in ameliorating or preventing AUD.
A LCOHOL USE DISORDER (AUD) is a multifaceted psychiatric disorder afflicting over 16 million Americans (Center for Behavioral Health Statistics and Quality, 2015) and costing the United States over $200 billion annually (Sacks et al., 2015) . Those suffering from AUD present with the inability to control their drinking, the tendency to prioritize drinking over responsibilities and activities, tolerance, withdrawal upon cessation, and continued proclivity to drink despite negative consequences (American Psychiatric Association, 2013) . Recent characterization of AUD astutely defines critical disorder phases as pre exposure "craving" (pre-occupation/anticipation), acute exposure (binge/intoxication), and postexposure (withdrawal/negative affect) (Koob, 2008; Koob and Volkow, 2010) . The development and regulation of AUD is believed to be a product of both genetic and environmental influences on brain function, as these factors may account for the predisposition to alcoholism (Koob, 2003; Pickens et al., 1991; Starkman et al., 2012) .
Recent research on alcohol exposure and subsequent changes in gene expression suggest that chemical modifications of the genome (epigenetic mechanisms) are important emerging molecular mechanisms in better understanding the pathophysiology of AUD and addictive behaviors (Feng and Nestler, 2013; Pandey et al., 2008a; Nestler, 2008, 2009; Starkman et al., 2012) . Epigenetic mechanisms can transiently or stably manipulate gene expression (Holliday, 2006 ) via DNA methylation, histone acetylation and methylation, and other less understood mechanisms (Kouzarides, 2007; Krishnan et al., 2014) . These modifications can occur concurrently to varying degrees at different loci within the epigenome, allowing for an extremely diverse array of modification "signatures" that regulate gene expression in unique ways, depending on the specific arrangement (Henkels and Khorasanizadeh, 2007; Jenuwein and Allis, 2001; Wang et al., 2008) . These mechanisms have recently been implicated in psychiatric disorders, including AUD (Kyzar et al., 2016a; Moonat et al., 2013; Nestler et al., 2016) , and warrant detailed discussion in this review article.
Studies of alcohol's effect on epigenetic signatures and gene expression within specific brain regions have revealed numerous modifications altering cell signaling and downstream regulation of AUD phase phenotypes (Koob and Volkow, 2010; Starkman et al., 2012) . The impact of epigenetic mechanisms beyond the adolescent and adult nervous system in AUD is widespread and continuing to be explored. The role of alcohol-induced epigenetic changes in fetal alcohol spectrum disorder (FASD) and peripheral organ damage, such as the liver, has been extensively reviewed elsewhere (Bekdash et al., 2014; Lo and Zhou, 2014; Mandrekar, 2011; Shukla and Lim, 2013) . Given the therapeutic potential of epigenetic manipulation in AUD, this review will focus on the available epigenetic studies (Figs 1 to 3) in AUD phenotypes focusing on histone acetylation, histone methylation, and DNA methylation mechanisms in specific brain regions crucial to addiction, such as the amygdala, frontal cortex (FC), hippocampus, and nucleus accumbens (NAc).
HISTONE ACETYLATION MECHANISM
Chromatin consists of repeated units of DNA wound around an octamer of histone proteins that organize and package nuclear genetic material (Bednar et al., 1998) . Histone proteins possess amino-terminal tail domains that can be post translationally altered via acetylation, methylation, and a variety of other modifications (Bannister and Kouzarides, 2011; Smolle and Workman, 2013) . Depending on the modification location and type, associated chromatin is remodeled to become more or less condensed. This configuration alters access of transcription factors (TFs) and other DNA-binding proteins, thereby regulating transcription (Guccione et al., 2006; Guertin and Lis, 2010; Kan et al., 2007; Li et al., 2011) .
Histone acetylation is a permissive mark established by histone acetyltransferase (HAT) activity, which adds an acetyl group to lysine residues on the N-terminal tails of histone proteins and generates open chromatin in a transcriptionally competent state (Bannister and Kouzarides, 2011; Marmorstein and Roth, 2001) . Conversely, histone deacetylases (HDACs) remove acetyl groups from histone tails. HATs and HDACs have been linked to neuronal differentiation, synaptic plasticity, cognitive function, and psychiatric disorders (Cho and Cavalli, 2014; Nestler et al., 2016; Pirooznia and Elefant, 2013; Yeh et al., 2004) . Recently, histone acetylation has been implicated in addiction mechanisms, including alcoholism (Krishnan et al., 2014; Kyzar et al., 2016a; Renthal and Nestler, 2009 ).
ALCOHOL-INDUCED HISTONE ACETYLATION AND THE REGULATION OF CREB
There is consistent evidence that acute and chronic alcohol exposure modulate histone acetylation in the amygdaloid circuitry leading to alcohol tolerance and dependence (Pandey et al., 2008a; Sakharkar et al., 2012) . Oftentimes, changes in acetylation occur at histone 3 lysine 9 (H3K9) and are regulated in specific addiction-related brain circuitry (BardagGorce et al., 2007; Finegersh and Homanics, 2014; Finegersh et al., 2015; Pandey et al., 2008a; Sakharkar et al., 2014b) . Furthermore, investigations into AUD have implicated altered epigenetic regulation of synaptic plasticity and gene expression in specific brain regions via cAMP response element-binding protein (CREB) and its regulated co-factor CREB-binding protein (CBP) (Correa et al., 2016; Guo W et al., 2011; Kyzar and Pandey, 2015; Pandey, 2003) .
Studies of ethanol (EtOH) exposure have revealed significant CREB and CBP pathway activation or attenuation in various brain regions. In the central and medial nucleus of the amygdala (CeA and MeA), acute EtOH exposure induces CREB activation and CBP expression while inhibiting HDAC activity (Pandey et al., 2008a,b; Sakharkar et al., 2012) . Accordingly, acute EtOH exposure increases H3K9ac and H4K8ac within the amygdala and up-regulates notable CREB target genes, including the synaptic plasticity-associated brain-derived neurotrophic factor (BDNF) and activity-regulated cytoskeleton-associated protein (Arc), neuropeptide Y (NPY), and prodynorphin (PDYN) (Fig. 1 ) (D'Addario et al., 2013; McCarthy et al., 2012; Pandey et al., 2008a,b) . These findings correlate with increased dendritic spine density within the CeA and MeA and a reduction in anxiety-like behaviors in rats (Moonat et al., 2011; Pandey, 2003; Pandey et al., 2008b; Sakharkar et al., 2012) . In the cerebellum, a brain region responsible for motor coordination that is negatively affected by alcohol, expression of the CBP-HAT, and associated histone H3 and H4 acetylation is reduced after chronic EtOH exposure, unlike the aforementioned brain regions (Guo W et al., 2011; Kalkhoven, 2004) .
Similarly, in a genetic model of AUD with comorbid anxiety, alcohol-preferring (P) rats possess inherently increased HDAC2 and decreased CREB and NPY levels in the amygdala compared to non-alcohol-preferring (NP) rats. Elevated HDAC2 expression in the CeA and MeA was correlated with decreased H3K9ac both globally and at promoters of Bdnf and Arc, which were innately less expressed in P rats as compared with NP rats. Upon EtOH exposure, P rats exhibited reduced anxiety-like behaviors and increased CREB activation, BDNF and Arc expression, and dendritic spine density in the CeA and MeA (Moonat et al., 2011; Pandey et al., 2005) . Similarly, amygdaloid HDAC2 siRNA infusion or systemic HDAC inhibitor, trichostatin A (TSA), treatment in P rats reduced anxiety and EtOH intake and normalized deficits in H3K9ac levels and NPY, BDNF, and Arc expression in the amygdala (Moonat et al., 2013; Sakharkar et al., 2014b) . Furthermore, infusion of NPY either intracerebroventricularly (ICV) or directly into the CeA of P rats was able to attenuate anxiety and alcohol-drinking behaviors and increase CREB activation and NPY levels (Gilpin et al., 2003 (Gilpin et al., , 2011 Zhang et al., 2010) . Notably, regions of the extended amygdala, such as the CeA, MeA, and bed nucleus of the stria terminalis (BNST), have been implicated in regulating the postexposure negative affective AUD phase (Koob and Volkow, 2010) . Together, these studies strongly support a critical role of CREB pathway activation and its interaction with HAT/HDAC-associated histone acetylation mechanisms, particularly within the amygdala, in regulating AUD (Fig. 1) .
HISTONE ACETYLATION MECHANISMS OF ALCOHOL TOLERANCE AND DEPENDENCE
As discussed above, acute EtOH exposure in animal models reduces anxiety and HDAC activity and induces histone acetylation and expression of NPY in the CeA and MeA (Pandey et al., 2008a; Sakharkar et al., 2012) . Likewise, HDAC2 is down-regulated in the mouse cortex after acute alcohol exposure, and reduced H3K9ac at the HDAC2 promoter possibly accounts for this down-regulation (Finegersh and Homanics, 2014) . Other studies have also indicated that acute EtOH differentially alters various isoforms of HDAC in the periphery and brain in rats, further suggesting the role of chromatin remodeling in the action of alcohol (L opezMoreno et al., 2015) .
Interestingly, an identical acute dose of EtOH administered 24 hours after the first dose generates rapid EtOH tolerance and fails to produce anxiolytic effects or inhibit amygdaloid HDAC activity (Fig. 1) , despite equivalent blood alcohol concentrations to nontolerant rats . Treatment with TSA attenuated tolerance to the anxiolytic effect of EtOH and increased levels of NPY, H3K9ac, and H4K8ac in the CeA and MeA of rats . These findings highlight the role of swift and dynamic epigenetic changes in modulating early molecular processes due to EtOH exposure, but these early changes can also serve as a useful molecular index of chronic tolerance that develops after long-term exposure to EtOH (Khanna et al., 1991 (Khanna et al., , 1992 (Khanna et al., , 1996 . Our laboratory has corroborated this understanding by investigating epigenetic mechanisms and gene expression similarities between rapid tolerance and chronic tolerance, finding that both are characterized by the development of tolerance to histone acetylation and anxiolytic effects of exposure ( Fig. 1) (Pandey et al., 2008a; Sakharkar et al., 2012; You et al., 2014) . Similarly, another laboratory reported that HDAC expression that was significantly altered by acute exposure returned to baseline levels after 8 repeated binge cycles in rats (L opez-Moreno et al., 2015) . This tolerance to the anxiolytic and other behavioral effects of alcohol in animals and humans (Debatin and Barbosa, 2006; Koob, 2008; Koob et al., 1987) can encourage increased alcohol consumption and subsequent development of dependence and postexposure withdrawal susceptibility (Tabakoff et al., 1986 . These changes remodel chromatin to a less condensed form that allows for transcription factors (TFs) to access genes, such as activated CREB and CBP binding, resulting in increased expression of CREB targets, such as neuropeptide Y (NPY), prodynorphin (PDYN), brain-derived neurotrophic factor (BDNF), and activity-regulated cytoskeleton-associated protein (Arc). These modifications and related gene products in the amygdala are known to reduce anxiety-like and drinking behaviors. Tolerance and chronic exposure to EtOH normalizes molecular signatures of the epigenome. Upon withdrawal or in the case of genetic predisposition to alcoholism, HDAC activity is increased, and the subsequent histone deacetylation condenses the chromatin and down-regulates the CREB pathway. This result in increased anxiety-like and drinking behaviors; decreased H3 and H4 acetylation; and decreased CBP, NPY, BDNF, and Arc expression. Ethanol will then recover normal chromatin from these states.
activation, CBP expression, NPY levels, and expression of synaptic plasticity-associated genes in the extended amygdala ( Fig. 1) (Pandey et al., , 2008a Sakharkar et al., 2012) . Furthermore, withdrawal from both acute and chronic EtOH exposure is characterized in part by the development of anxiety (Driessen et al., 2001; Koob, 2003; Pandey et al., 2003) . TSA, when administered to rats experiencing alcohol withdrawal, prevents anxiety-like behaviors and rescues the deficits in H3K9ac, BDNF, Arc, and NPY expression within the amygdaloid brain regions (Pandey et al., 2008a; You et al., 2014) . In vitro studies have shown that TSA induces cortical expression up-regulation of the glutamate NMDA receptor, NR2B. Interestingly, the NR2B gene possesses a functional binding site for CREB that was found to be responsive to EtOH and is up-regulated via H3K9ac in cases of chronic EtOH exposure and postexposure withdrawal, and has been extensively linked to neuroplasticity, long-term potentiation, and addiction regulation (Kalivas and Volkow, 2011; Qiang et al., 2011; Rani et al., 2005) . These findings cumulatively suggest the importance of histone acetylation and HDACs in regulation of multiple phases of AUD and accentuate the potential role of HDAC inhibition as treatment (Fig. 3) .
Several studies from our and other laboratories have consistently demonstrated the molecular and behavioral impact of treatment with HDAC inhibitors. In addition to aforementioned studies, TSA and vorinostat (SAHA) were found to attenuate voluntary alcohol drinking in various animal models of alcohol intake (Jeanblanc et al., 2015; Sakharkar et al., 2014b; Warnault et al., 2013) , and TSA treatment also inhibits alcohol-induced reactive oxygen species (ROS) in vitro (Agudelo et al., 2011) . Somewhat contrary to these findings, Qiang and colleagues (2014) investigated chronic EtOH exposure in mice and reported that systemic TSA treatment accelerated drinking. However, the authors note that they initiated treatments in EtOHna€ ıve rodents and continued treatment before each EtOH exposure, while other studies provide HDAC inhibitors in conditions where chromatin architecture is innately condensed or perturbed by HDACs secondary to EtOH exposure.
The effects of other HDAC inhibitors have also been explored. Sodium butyrate (NaB) is a class I and class II HDAC inhibitor, and MS-275 is a class I HDAC inhibitor. Intraperitoneal (IP) and ICV administration of NaB and MS-275, respectively, were found to independently decrease operant self-administration of alcohol, EtOH preference, and relapse-like behaviors in alcohol-dependent rats. Additionally, both treatments variably altered histone acetylation in brain regions associated with addiction and reward pathways (Jeanblanc et al., 2015; Simon-O'Brien et al., 2015) . Another study indicated that in vitro exposure to various HDAC inhibitors prevented the gamma-aminobutyric acid (GABA) hyposensitivity of dopaminergic neuronal firing in the ventral tegmental area (VTA) that is typically induced by chronic EtOH exposure in mice. Furthermore, this appears to be regulated by HDAC2-mediated deficits in H3K9ac in the VTA (Arora et al., 2013) . Finally, valproic acid has been shown to selectively induce the degradation of HDAC2 (Kr€ amer et al., 2003) and to dose dependently decrease EtOH intake and preference in rats (Al Ameri et al., 2014) . Together, these findings highlight the therapeutic potential of targeting epigenetic mechanisms in alcohol dependence, acute exposure tolerance, and postexposure withdrawal when treating AUD.
HISTONE ACETYLATION IN ADOLESCENT EXPOSURE TO ALCOHOL
Adolescent alcohol consumption is an expanding subject in AUD and epigenetic research as adolescent exposure increases intake, risk of dependence, and addictive behaviors in adults (Kyzar et al., 2016a; Nixon and McClain, 2010) . While adolescents are more resistant to locomotor disturbances, anxiolysis, and withdrawal-induced seizures, they are increasingly sensitive to withdrawal-induced anxiety, thus encouraging escalating alcohol intake and binge drinking (Chung et al., 2008; Pandey et al., 2015; Sakharkar et al., 2014a; Spear and Varlinskaya, 2005) . Although the field of study is recently burgeoning, already there is a plethora of findings that suggest repeated adolescent EtOH exposure results in persistent epigenetic modifications within the specific neurocircuitry of addiction that modulates AUD phase regulation, such as that of alcohol intake and anxiety later in life (Kyzar et al., 2016a; Pandey et al., 2015) .
Studies have begun revealing a complex network of histone acetylation changes in various brain regions secondary to acute and chronic alcohol exposure in adolescents. For instance, acute EtOH exposure in adolescent rats causes attenuated HDAC activity in the amygdala and BNST (Sakharkar et al., 2014a) . Similarly, a study also showed increased H3K9ac, H4K5ac, and H4K12ac within the prefrontal cortex (PFC) in an adolescent binge-drinking model (Montesinos et al., 2016) . Additionally, binge-like exposure in adolescent rats induced HAT activity in the PFC, resulting in increased H3Kac and H4Kac both globally and at promoters of genes such as cfos, which are believed to regulate addiction in other parts of the brain by modulating synaptic plasticity or transcription mechanisms (Pascual et al., 2012) . In the NAc, global histone H3 and H4 acetylation are also increased (Pascual et al., 2009) . These regions possibly experience transcription activation at important, specific genomic locations relevant to AUD.
In the amygdala, however, binge-like drinking via the adolescent intermittent ethanol (AIE) model induces persistent increases in global HDAC activity and HDAC2 expression alongside decreased H3K9ac both globally and at the promoter regions of Bdnf and Arc in adulthood. Predictably, these findings correlate with significant decreases in Bdnf and Arc gene expression and dendritic spine density, particularly in the CeA and MeA of rats . This is especially interesting as adult rats who underwent AIE also exhibit increased anxiety and alcohol intake that is abated by TSA treatment .
In the hippocampus, both adolescent and adult tissues do not exhibit global histone H3 or H4 acetylation changes after binge-like EtOH exposure (Pascual et al., 2009 ). Interestingly, Sakharkar and colleagues (2016) reported that adult rats after AIE showed significant increases in hippocampal HDAC activity. Furthermore, they present with decreased hippocampal global CBP and H3K9ac levels as well as H3K9/14ac levels at the Bdnf exon IV promoter (Sakharkar et al., 2016) . Importantly, adult TSA treatment reversed the changes in hippocampal histone acetylation of Bdnf gene and normalized expression of dysregulated hippocampal neurogenesis markers (Sakharkar et al., 2016) . Once again, these findings implicate neuroplasticity of certain brain regions in regulating alcoholism (Kyzar et al., 2016a; Pascual et al., 2009 ) and highlight the therapeutic potential of HDAC inhibitors (Falkenberg and Johnstone, 2014; Kyzar and Pandey, 2015) . Considering the imperative role that environment and epigenetics play in adolescent development and the ample evidence regarding epigenetic regulation of addiction neurocircuitry in adolescent alcohol exposure, it is clear that more investigation is warranted regarding this atrisk population.
HISTONE METHYLATION MECHANISMS
Recently, histone methylation has gained traction in epigenetic research and so far has been linked to cancer, development, neuroplasticity, learning, addiction, and anxiety (Covington et al., 2011; Kim et al., 2013; Pattaroni and Jacob, 2013; Subbanna and Basavarajappa, 2014; Tachibana et al., 2002) . Histone methyltransferases (HMTs) transfer 1 or more methyl groups from the methyl donor, s-adenosyl methionine (SAM), onto histone N-terminal tail lysine or arginine residues, and histone demethylators (HDMs) remove methyl groups from histones. Arginine residues can maintain 1 or 2 methyl groups, and lysine residues can be mono-, di-, or tri-methylated (Krishnan et al., 2014; Pattaroni and Jacob, 2013) . Unlike histone acetylation, histone methylation has variable effects on transcription depending on the modified residues, interactions with other epigenetic factors, and the valence of methylation.
HISTONE METHYLATION AS AN EPIGENETIC REGULATOR IN ALCOHOLISM
Histone methylation is largely understudied relative to histone acetylation and DNA methylation, but recent findings have revealed the critical role it plays in regulating psychiatric disorders, including AUD. For example, it has been shown that acute EtOH exposure in mice significantly increased levels of H3K4me3, an activating mark often found near transcription start sites, in the cortex (Finegersh and Homanics, 2014) . Similarly, another study found the activating H3K4me2 mark to be increased alongside histone acetylation at the promoters of TFs linked to synaptic plasticity and learning within the PFC of adolescent rats after binge-like alcohol exposure (Pascual et al., 2012) .
Repressive histone methylation marks in the cortical structures have also emerged as important regulators of AUD. For instance, Qiang and colleagues (2011) investigated cell cultures of mouse cortical neurons and showed that binge-like EtOH exposure decreased the suppressive H3K9me2 and H3K9me3 marks at the aforementioned NR2B NMDA receptor gene. Furthermore, the decrease in repressive H3K9 methylation markers correlated with a likely causative decline in HMT expression, including that of G9a, Setdb1, and Suv39h1 (Qiang et al., 2011) . Of these, G9a is largely responsible for H3K9me2 production (Shinkai and Tachibana, 2011; Tachibana et al., 2002 Tachibana et al., , 2008 and has recently been investigated in addiction and alcohol exposure (Covington et al., 2011; Maze et al., 2010; Subbanna et al., 2013; Sun et al., 2012) . More specifically, G9a has emerged as a key contributor to alcohol-induced gene expression regulation in FASD (Basavarajappa and Subbanna, 2016) . Recently, the HMT known as PR domain-containing 2, with ZNF domain (PRDM2) was found to regulate postdependent AUD phenotypes, including alcohol intake and stress-induced relapse. Interestingly, knockdown of Prdm2 in nondependent rat dorsomedial PFC prompted postdependent behaviors, revealing the future treatment potential of HMT manipulation (Barbier et al., 2016) .
In the amygdala of adult rats, acute EtOH exposure significantly reduces H3K27me3 at the promoters of Pdyn and Pnoc (prepronociceptin) (D'Addario et al., 2013) , which have been implicated in alcohol dependence (Karpyak et al., 2013; Xuei et al., 2006) . Our laboratory found that adolescent alcohol exposure altered histone methylation in the amygdala in adulthood as well as a propensity to drink and exhibit more anxiety than their control counterparts (Kyzar et al., 2016b; Pandey et al., 2015) . Specifically, the lysine demethylase, LSD1, and its neuron-specific isoform, Lsd1+8a, which demethylate H3K4me2/3 and H3K9me2/ 3, were both persistently down-regulated in the amygdala. Furthermore, an associated increase in global and Bdnf exon IV-specific H3K9me2 but not H3K4me2 was observed in rats exposed to EtOH in adolescence compared to controls. Acute EtOH challenge to adult rats after AIE attenuated anxiety-like behavior and deficits in Lsd1+8a expression as well as increase in H3K9me2 levels at Bdnf exon IV in the amygdala (Kyzar et al., 2016b ). Much like previously described histone acetylation reports, these data suggest adolescent exposure to alcohol results in a decrease in gene activation within the amygdala and increased activity within the PFC secondary to epigenetic reprogramming, specifically regulating the expression of genes that modulate synaptic plasticity and possibly contributing to adult psychopathology. Overall, these findings encourage future exploration, as current studies focus on the PFC and the amygdala.
HISTONE METHYLATION IN HUMAN ALCOHOLICS
Few human studies of histone methylation currently exist, but the advancements in RNA and ChIP-sequencing have supported recent interest in the field. Specifically, the Harris laboratory spearheaded an exploration of genomewide H3K4me3 activation marks in postmortem hippocampus samples of alcohol abusers, revealing a distinct pattern of H3K4me3 at gene networks known to be functionally interconnected and either potentially or definitively linked to addiction regulation (Farris et al., 2015) . Similarly, a study of the amygdala and FC of postmortem tissue in alcoholics found multiple H3K4 HMTs to be up-regulated in addition to a global increase in H3K4me3 (Ponomarev et al., 2012) . Another study specifically reporting on genome-wide associations of alcohol withdrawal symptoms described multiple significant polymorphisms in the gene for a HDM known as KDM4C , implicating histone methylation as a regulator of AUD phenotypes that warrants further investigation. Overall, data regarding histone methylation in human alcoholics are intriguing but limited.
DNA METHYLATION MECHANISMS
DNA methylation is a repressive mark that is characterized by methylation of the cytosine pyrimidine ring at carbon-5. Dense regions of CpG dinucleotides (CpG islands) are often found near promoter transcription start sites, and their methylation is generally known to block TFs and silence associated genes (Comb and Goodman, 1990; Li and Zhang, 2014) . Furthermore, some repressor complexes and TFs gravitate toward methyl-binding proteins like MeCP2 and subsequently modify histones, thus further regulating gene expression (Chahrour et al., 2008; Jones et al., 1998; Nan et al., 1998) . To establish DNA methylation, DNA methyltransferases (DNMT1, 3a, and 3b) relocate a methyl group from SAM to the target cytosine. Importantly, these DNMTs are abundant in fully differentiated adult neurons and are believed to play a critical role in gene regulation (Feng et al., 2005; Szulwach et al., 2011) . Methylation removal from DNA also occurs, presumably via removal of the methyl group or secondary to inhibition or loss of DNMT activity (Wu and Zhang, 2010) . Notably, multiple base-excision and nucleotide-excision repair mechanisms result in demethylation (Ma et al., 2009; Wu and Zhang, 2010) . Furthermore, recent investigations into the ten-eleven translocation (TET) family of enzymes that hydrolyze 5-methylcytosine to 5-hydroxymethylcytosine (5hmC) suggest 5hmC may alter transcription regulation by inhibiting identification by DNA-binding enzymes such as DNMT1 or by activating the base-excision repair pathway (Guo JU et al., 2011; Jin et al., 2010; Valinluck and Sowers, 2007) .
DNA METHYLATION AS AN EPIGENETIC REGULATOR IN ANIMAL MODELS
Dysregulated DNA methylation mechanisms have been implicated in psychiatric disorders including AUD (Nestler et al., 2016; Starkman et al., 2012) . Studies on the effects of alcohol exposure on DNA methylation remain conflicting after decades of research. An early study of rats chronically exposed to EtOH reported more relaxed chromatin specifically in neurons and implicated nonhistone protein-DNA interactions (Mahadev and Vemuri, 1998) . To explain this phenomenon, multiple debatable theories and contrary findings have emerged. First, chronic EtOH consumption commonly leads to folate and vitamin B deficiencies, resulting in increased homocysteine levels and down-regulation of SAM (Niculescu and Zeisel, 2002) . However, increased homocysteine has been elsewhere linked to global hypermethylation and presumably more condensed and transcriptionally silenced chromatin in alcoholics (B€ onsch et al., 2004a) . Second, genomic insults secondary to alcoholism may contribute to DNA hypomethylation upon base-excision repair (Chen et al., 2011) . And third, DNMT3b expression was found to be down-regulated in adult alcoholics, but it was notably associated with genetic hypermethylation, not hypomethylation as one might expect (B€ onsch et al., 2006) . Ultimately, there are no conclusive theories to explain global neuronal hypomethylation. In fact, recent evidence in animal models counters the previously detailed dogma of extensive global DNA hypomethylation in neurons secondary to chronic alcohol exposure. Rather, it is possible that acute EtOH exposure may reduce DNA methylation, while chronic exposure results in DNA hypermethylation in various brain regions (Fig. 2) .
There are few studies investigating acute EtOH exposure on global DNA methylation; nonetheless, in vitro and in vivo evidence suggests that acute alcohol exposure and alcohol metabolites inhibit DNMT expression and activity, including that of brain tissues (Garro et al., 1991; Zhang et al., 2014) . More specifically, DNMT3a expression was found to be down-regulated in astrocytes secondary to acute alcohol exposure in animals . Furthermore, a study of adolescent rats showed that DNMT activity was attenuated in both the BNST and the amygdala after acute alcohol exposure (Sakharkar et al., 2014a) . While these studies are preliminary and limited in number, their contrast to chronic alcohol exposure-induced DNA methylation signatures encourages exploration of DNA methylation in different phases of AUD.
Chronic exposure, contrary to acute exposure, appears to induce global hypermethylation of DNA in multiple brain regions. For instance, in chronically exposed adult mice, there is reportedly an increase in DNMT1 expression within the NAc (Warnault et al., 2013) . Similarly, another study which examined the NAc and medial prefrontal cortex (mPFC) of postdependent rats after weeks of abstinence showed a persistent increase in global DNA methylation as well as a persistent increase in DNMT1 expression that was associated with the down-regulation of a cluster of synaptic genes specifically within mPFC neurons (Barbier et al., 2015) . These studies cumulatively suggest that chronic EtOH exposure induces global DNA hypermethylation in various brain regions of animal models associated with addiction and AUD. Furthermore, the few studies available suggest that acute but not chronic EtOH exposure may attenuate DNMT activity (Fig. 2) .
The effect of acute and chronic EtOH exposure on DNA methylation of specific promoter sequences in animal models has also been investigated. For instance, in a study examining the effect of acute EtOH exposure on tissue plasminogen activator (tPA) in rat astrocytes-due to astrocytes' essential role in neuroplasticity-the results demonstrated that acute in vitro alcohol exposure inhibited DNMT activity and DNMT3a expression, decreased DNA methylation at the tPA promoter, and increased tPA expression, suggesting a potential indirect role of DNA methylation in regulating neuroplasticity upon alcohol exposure . A study of chronic EtOH exposure in cultured mouse cortical neurons showed a reduction in DNA methylation at the NR2B promoter, resulting in increased expression of NR2B (Marutha Ravindran and Ticku, 2004) . Similarly, chronic EtOH exposure in fetal rats reportedly induced hypermethylation of Bdnf and subsequent reduction in BDNF protein expression within the olfactory bulb, suggesting yet again a role of alcohol-induced epigenetic mechanisms in regulation of synaptic plasticity (Maier et al., 1999) .
Similar to HDAC inhibition, treatments of alcohol dependence models suggest that DNMT inhibition provides a promising therapeutic option in AUD by altering both global-and promoter-specific DNA methylation in brain regions central to addiction neurocircuitry (Fig. 3) . Mice and rats given DNMT inhibitors, such as systemic 5-azacytidine and ICV RG108, have exhibited significantly decreased alcohol intake and binge-like behaviors accompanied by decreased global DNA methylation within the NAc and increased synaptic plasticity-associated transcription (Barbier et al., 2015; Warnault et al., 2013) . Furthermore, DNMT inhibition via ICV administration of RG108 also reversed alcohol-induced hypermethylation and changes in synaptotagmin 2 (Syt2) mPFC expression, which has been confirmed to regulate alcohol-drinking behaviors (Barbier et al., 2015) . We also recently found that decreased expression of GADD45b increased Bdnf DNA methylation in the NAc and promoted alcohol-drinking behaviors in mice (Gavin et al., 2016) . These combined studies emphasize the importance of DNA methylation intervention in regulating chromatin remodeling and gene expression in alcoholism and show promise for DNMT inhibition as a treatment of AUD.
DNA METHYLATION IN HUMAN ALCOHOLICS
Genome-wide and promoter-specific DNA methylation study of peripheral blood cells is a newly developing approach to isolating genes of interest and potential biomarkers in humans. At a time when biomarkers for acute and chronic substance abuse are a necessity (Andersen et al., 2015; Volkow et al., 2015) , DNA methylation has emerged as a potentially reliable signature of environmental exposures for future clinical testing (Ladd-Acosta, 2015 Fig. 2 . Hypothetical model indicating possible changes in DNA methylation after acute ethanol (EtOH), chronic EtOH exposure, and withdrawal upon cessation. Animal studies consistently report that acute EtOH exposure induces global DNA demethylation and presumably relaxed chromatin within various brain nuclei, altering transcription factors (TFs) access and associated gene expression. Chronic exposure in animal and human samples reportedly increases global DNA methylation in several brain regions and peripheral blood samples. Based on these findings and the role chromatin remodeling plays in anxiety and drinking behavior, we hypothesize that alcohol withdrawal results in especially hypermethylated DNA and presumably condensed chromatin as a consequence of dysregulated epigenetic mechanisms. It is possible that DNMT inhibitor treatment (Tx) or acute EtOH exposure may lead to relaxed chromatin architecture due to DNMT inhibition.
For example, 2 studies of alcoholic patients in the postexposure withdrawal phase of AUD either found significant hypermethylation or no change at the dopamine transporter gene (DAT), although both reported a significant negative correlation or clear trend for negative correlation between DAT methylation and craving Nieratschker et al., 2014) . A separate study conversely reported decreased DNA methylation at a single CpG island site in alcoholic patients relative to controls (Jasiewicz et al., 2015) . A relevant study that investigated DNA methylation of the monoamine oxidase A gene (MAOA) reported a significant association between the degree of alcohol dependence in female patients and the level of MAOA methylation (Philibert et al., 2008) . A very recent study detected methylation changes of extremely heavy daily drinkers at GABA receptor genes (GABRD and GABBR1), providing a potential future biomarker of current or recent heavy drinking (Liu et al., 2016) . Furthermore, the previously discussed chronic EtOH-induced hypomethylation of NR2B in alcohol-dependent rodents is also seen in humans, and the gene is increasingly hypomethylated depending on AUD severity (Biermann et al., 2009a) . While not currently clear, these studies suggest potential for future biomarkers and further investigations into the DNA methylation regulation of synaptic neurotransmission in AUD.
Other gene-specific investigations have reported significant changes in pathways relevant to alcohol craving, such as pro-opiomelanocortin (POMC) and alpha-synuclein (SNCA) (B€ onsch et al., 2004b , 2005a Foroud et al., 2007) . Specifically, a cluster of DNA methylation site alterations within the POMC promoter was found to be correlated with alcohol craving in both postexposure and pre exposure craving phases of AUD (Muschler et al., 2010) . Additionally, certain POMC CpG sites were reportedly hypermethylated in particular populations of dependent patients . At the SNCA promoter, hypermethylation was reported in alcoholics in the acute exposure and postexposure withdrawal phases (B€ onsch et al., 2005b) .
Genome-wide studies have also emphasized a variety of genes known to be involved in alcohol metabolism and related reward circuitry. For instance, 1 study compared alcoholics to their nondependent siblings and revealed several genes of interest with altered methylation signatures, including that of an aldehyde dehydrogenase (ALDH1L2) involved in eliminating alcohol metabolites, a GABA receptor (GABRP) suggestive of decreased GABA binding in alcoholics, a glutamate decarboxylase (GAD1) that has been well studied in alcohol-related GABA production, and a dopamine beta-hydroxylase (DBH) that has been strongly linked to alcohol tolerance . Patient AUD phase, however, is unclear. A separate preliminary genomewide investigation also reported epigenetically altered alcohol metabolism in several similar gene clusters and pathways previously associated with alcoholism, such as the aldehyde dehydrogenase family, stress pathways, and inflammatory responses .
Recent studies have begun to combine genome-wide analysis of DNA methylation with that of intriguing phenotypic metrics. For instance, a recent study confirmed a genomewide report of hypomethylation at the ganglioside-induced differentiation-associated protein 1 (GDAP1) gene and further found that GDAP1 DNA methylation was significantly HDAC Inhibition -EtOH intake with genetic predisposition -Anxiety -Tolerance to anxiolytic effects of EtOH -EtOH-induced ROS in human brain -Synaptic plasticity at Amygdala . Promising pharmacotherapy treatment of alcoholism and withdrawal includes DNA methyltransferase (DNMT) inhibitors, histone deacetylase (HDAC) inhibitors, and possibly histone methyltransferase (HMT) inhibitors. Current studies suggest these interventions often mimic the effects of ethanol (EtOH) by relaxing chromatin and modulating anxiolysis, synaptic plasticity, and drinking behaviors. They have been shown to alter epigenetic mechanisms, prevent alcohol-induced reactive oxygen species (ROS) in neurons, and increase synaptic plasticity within critical brain regions that regulate addiction and alcoholism, such as the nucleus accumbens (NAc) and the amygdala. Presumably as a result, numerous studies have shown that DNMT and HDAC inhibitors reduce alcohol-intake, anxiety-like behaviors, and binge-like drinking behaviors. HMT inhibitors are a promising yet currently unexplored treatment consideration in AUD.
associated with severity of patient with AUD (Br€ uckmann et al., 2016) . Another recent study examined DNA methylation in monozygotic twins with discordant AUD status and complemented this work with personality evaluation and MRI imaging during an impulsiveness task (Ruggeri et al., 2015) . They found a significant association of hypermethylation at the 3 0 -protein-phosphatase-1G gene (PPM1G) with AUD as well as 2 established risk factors of AUD-adolescent escalation of alcohol intake and impulsivity (Ruggeri et al., 2015) . These multifaceted approaches garner invaluable information considering the complexity of AUD and support the notion that stratification of patient phenotypes assists in elucidating specific underlying mechanisms.
The genes noted here are believed to play a significant role in previously recognized AUD regulation mechanisms, but the number of other gene-specific and genome-wide studies has greatly increased in recent years, resulting in a plethora of gene candidates available for further investigation . As genome-wide epigenetic studies continue to be produced in different populations, it is likely that more unrecognized mechanisms will begin to unfold and the role of DNA methylation in AUD can further be elucidated.
DNA METHYLATION IN HUMAN POSTMORTEM BRAIN TISSUE
Postmortem tissue studies of humans diagnosed with AUD provide an important opportunity to investigate brain region-specific changes in DNA methylation. Unfortunately, such studies are significantly limited in breadth of tissue and sample size due to obvious restrictions in tissue availability, and so far, they have elicited a variety of results. Minimal investigation of postmortem precuneus and putamen brain regions of alcoholics has been completed, although gene networks involved in the immune and inflammatory response, lipid metabolism, and gastrointestinal disease have been identified as having significantly altered DNA methylation status in alcoholics (Hagerty et al., 2016) .
In the amygdala and FC of alcoholics, studies are more extensive, although results vary greatly. In 1 study, global DNA hypomethylation and decreased transcription of DNMT1 were found, contrary to several animal studies (Ponomarev et al., 2012) . Similar studies in human FC detected extensive hypermethylation in males but not females or no such change (Manzardo et al., 2012) . Interestingly, the Ponomarev study also suggested that GC content altered the dysregulation pattern of genes. Specifically, GC-rich and GC-poor gene networks were respectively up-regulated and down-regulated in alcoholics (Ponomarev et al., 2012) .
These studies have also revealed epigenetic signature shifts and dysregulation in a myriad of gene networks, including synaptic transmission genes in FC neurons of alcoholics, which is consistent with epigenetic animal studies (Krishnan et al., 2014; Ponomarev et al., 2012) . Similarly, multiple genes involved in chromatin remodeling, histone deacetylation, and transcription repression were significantly up-regulated in the amygdala and FC of alcoholics (Ponomarev et al., 2012) , and several histone gene promoters were found to be heavily methylated in the FC (Manzardo et al., 2012) , echoing the growing relevance of histone regulation in AUD.
Upon investigation of specific genetic loci, Taqi and colleagues (2011) investigated known PDYN CpG polymorphisms associated with increased risk of alcoholism and discovered differential DNA methylation in the postmortem PFC of alcoholics. This study has specifically emphasized the value of combining genome-wide population studies with epigenomic studies to effectively isolate risk-associated epigenomic shifts in certain populations. Other studies have begun investigating comorbidities and revealed altered TET1 expression in PFC of comorbid psychotic and alcoholic postmortem brains, broadening the scope of alcohol-induced chromatin remodeling (Guidotti et al., 2013) . Although the study of postmortem epigenomic signatures in alcoholism is in its infancy, investigations of various brain regions will likely continue to increase, hopefully elucidating the significance of these findings and guiding animal model investigations as well.
CONCLUSIONS
We have provided an evaluation of well-characterized epigenetic regulation of AUD phenotypes via modulation of gene expression within brain circuitry pivotal to anxiety, tolerance, dependence, and withdrawal regulation (Figs 1 to 3) . Across diverse epigenetic pathways in preclinical and human studies, some consistent notions have emerged. 1. A distinct epigenetic signature is present in unique phases of AUD and potentially varies based on disease phase and severity. Koob and Volkow (2010) elegantly portrayed phases of AUD as pre exposure "craving" (preoccupation/anticipation), acute exposure (binge/intoxication), and postexposure (withdrawal/negative affect). The reviewed studies consistently identified unique epigenetic regulation in postdependence, acute exposure/bingedrinking, and withdrawal states. Similarly, a very recent review concluded that 3 domains of addictive disorders, which correlate with the aforementioned phases of AUD, could be utilized to guide genetic, clinical, and therapeutic studies of the complex and multifaceted addiction disorders (Kwako et al., 2016) . Alcoholics present with extremely varied levels of dependence, exposure, tolerance, and withdrawal symptoms. Perhaps this complexity contributes to the rare correspondence of results among studies and the everincreasing list of genes of interest. Notably, preclinical studies that specifically study the withdrawal phase have had promising success in epigenetic investigation (Biermann et al., 2009a; Hillemacher et al., 2009b; Pandey et al., 2003 Pandey et al., , 2008a Wang et al., 2012) . Furthermore, previous attempts to stratify patients in manners such as Lesch's typology have provided intriguing insights, such as revealing a potential relationship between DNA methylation of homocysteine-induced endoplasmic reticulum protein (HERP) and drinking by type (Biermann et al., 2009b; Bleich et al., 2006) . It will be important going forward to critically stratify subject populations at least by disease severity and AUD phase upon sample retrieval to further understand the phases of alcohol abuse and severity of disease, as they are likely uniquely epigenetically regulated. 2. The synaptic plasticity and interconnectivity of brain regions involved in drinking, craving, reward, or negative affect consistently prove instrumental to the AUD and associated phenotypes across various epigenetic mechanisms reviewed here. The CREB pathway, which modulates connectivity and synaptic plasticity via BDNF and Arc expression, has repeatedly emerged an important molecular mechanism in alcoholism and addiction (Carlezon et al., 2005; Guo W et al., 2011; McCarthy et al., 2012; Pandey, 2003; Pandey et al., 2004) . Upstream and downstream regulation of epigenetic processes in the amygdala, cerebellum, PFC, NAc, and other brain regions has contributed to acute exposure effects, tolerance, adolescent exposure-induced phenotypes, and withdrawal effects (Krishnan et al., 2014; Maze and Nestler, 2011; Moonat et al., 2013; Pandey et al., 2008a Pandey et al., , 2015 Sakharkar et al., 2016) . Recently, epigenetic transgenerational effects of drug exposure have been implicated in addiction as well (Rachdaoui and Sarkar, 2014; Vassoler et al., 2013) .
LIMITATIONS
There are certainly limitations to be considered in AUD epigenetic research. First, chronic alcohol exposure impacts many non neuronal tissues, resulting in substantial and perhaps confounding or mediating sequelae. For example, blood sample cell composition shifts in alcoholics versus controls may alter findings. Notably, there are correction methods available for the composition shifts for DNA methylation, and future studies should be diligent in accounting for such changes (Houseman et al., 2012; Jaffe and Irizarry, 2014) .
Second, there is reasonable concern as to whether or not epigenetic signatures from blood can serve as reliable proxies for the brain because of the tissue-specific nature of epigenetic mechanisms. While 1 study investigated DNA methylation signatures in brain regions relative to blood samples and concluded that blood-based studies offered limited value beyond the cortex (Hannon et al., 2015) , several other studies have reported significant similarity in interindividual variation between blood samples and distinct brain regions (Davies et al., 2012; Ewald et al., 2014; Tylee et al., 2013) . Notably, the value of blood biomarkers remains a promising opportunity for study and clinical application, regardless.
A third limitation resides in the sheer complexity of AUD, which is characterized by widely varied severity in multiple phases, each affected by environmental and genetic influences. This complexity and the emerging understanding that individual phases of AUD are uniquely regulated makes disease phase and severity stratifications important. It is possible that discrepancies between studies occur due to a lack of appropriate patient stratification. For instance, some studies report on "healthy" undiagnosed individuals based on their self-reported drinking, stratify the population as drinker versus nondrinker, or do not provide sufficient information regarding the current phase of patients with AUD (Philibert et al., 2012; Zhang et al., 2011; Zhu et al., 2012) .
The importance of accurate disease characterization and severity stratification in epigenetic analyses is further highlighted in a recent pair of studies. In the first study, selfreported alcohol intake of patients with unknown AUD status was used for DNA methylation analysis (Philibert et al., 2012) , while the second study specifically included patients recruited from alcohol treatment centers who consumed significantly more alcohol than the previous study (Philibert et al., 2014) . The latter study detected low-grade changes and effectively determined a widespread shift in DNA methylation associated with acute sustained intake of alcohol, suggesting that epigenetic signatures in peripheral mononuclear cells can be used to monitor alcohol use when patients are effectively selected and grouped.
FUTURE WORK
The study of specific effects of AUD phases on neuroconnectivity has potential to usher in a more comprehensive understanding of neural adaptations and the value of targeting synaptic plasticity pathways for future addiction treatment. However, the recent evolution of epigenome-wide mapping continues to reveal novel gene network pathways perturbed by AUD, such as inflammation-related pathways, and more studies are needed in this direction.
To date, both systemic and brain-specific interventions with HDAC inhibitors and DNMT inhibitors decrease anxiety-like and alcohol-drinking behaviors and increase synaptic plasticity at the NAc and amygdala (Agudelo et al., 2011; Barbier et al., 2015; Pandey et al., 2008a; Sakharkar et al., 2016; Simon-O'Brien et al., 2015; Warnault et al., 2013) (Fig. 3) , but HMT inhibitors have yet to be fully explored. These recent advances provide inspiration for future investigation into HMTs and the potential value of histone acetylation and demethylation induction. Furthermore, epigenetic mechanisms not discussed here, such as histone phosphorylation, ubiquitylation, ribosylation, and sumoylation, are as of yet poorly defined (Kouzarides, 2007) , and contemporary AUD literature rarely considers these nebulous mechanisms. Moving forward, the elucidation of their mechanisms and subsequent study of their potential roles in AUD will likely advance.
Despite the complex nature of AUD and epigenetics, the robust indication of the importance of epigenetic mechanisms in AUD development, maintenance, and attenuation in multiple phases of the disorder presented here ultimately provides a favorable environment for achieving effective and innovative future treatments for those afflicted with AUD.
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